Biomarkers and Seaweed-Based Nutritional Interventions in Metabolic Syndrome: A Comprehensive Review

Overview

Journal Mar Drugs

Publisher MDPI

Specialties Biology
Pharmacology

Date 2024 Dec 27

PMID 39728125

Authors

Ana Valado

Margarida Cunha

Leonel Pereira

Affiliations

Soon will be listed here.

Abstract

Metabolic Syndrome (MetS) is a complex, multifactorial condition characterized by risk factors such as abdominal obesity, insulin resistance, dyslipidemia and hypertension, which significantly contribute to the development of cardiovascular disease (CVD), the leading cause of death worldwide. Early identification and effective monitoring of MetS is crucial for preventing serious cardiovascular complications. This article provides a comprehensive overview of various biomarkers associated with MetS, including lipid profile markers (triglyceride/high-density lipoprotein cholesterol (TG/HDL-C) ratio and apolipoprotein B/apolipoprotein A1 (ApoB/ApoA1) ratio), inflammatory markers (interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-α), plasminogen activator inhibitor type 1 (PAI-1), C-reactive protein (CRP), leptin/adiponectin ratio, omentin and fetuin-A/adiponectin ratio), oxidative stress markers (lipid peroxides, protein and nucleic acid oxidation, gamma-glutamyl transferase (GGT), uric acid) and microRNAs (miRNAs) such as miR-15a-5p, miR5-17-5p and miR-24-3p. Additionally, this review highlights the importance of biomarkers in MetS and the need for advancements in their identification and use for improving prevention and treatment. Seaweed therapy is also discussed as a significant intervention for MetS due to its rich content of fiber, antioxidants, minerals and bioactive compounds, which help improve cardiovascular health, reduce inflammation, increase insulin sensitivity and promote weight loss, making it a promising nutritional strategy for managing metabolic and cardiovascular health.

References

Saklayen M . The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep. 2018; 20(2):12. PMC: 5866840. DOI: 10.1007/s11906-018-0812-z. View

Rochlani Y, Pothineni N, Kovelamudi S, Mehta J . Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Ther Adv Cardiovasc Dis. 2017; 11(8):215-225. PMC: 5933580. DOI: 10.1177/1753944717711379. View

Vodouhe M, Marois J, Guay V, Leblanc N, Weisnagel S, Bilodeau J . Marginal Impact of Brown Seaweed and Extract on Metabolic and Inflammatory Response in Overweight and Obese Prediabetic Subjects. Mar Drugs. 2022; 20(3). PMC: 8951415. DOI: 10.3390/md20030174. View

Valado A, Pereira M, Caseiro A, Figueiredo J, Loureiro H, Almeida C . Effect of Carrageenans on Vegetable Jelly in Humans with Hypercholesterolemia. Mar Drugs. 2019; 18(1). PMC: 7024328. DOI: 10.3390/md18010019. View

Aoe S, Yamanaka C, Ohtoshi H, Nakamura F, Fujiwara S . Effects of Daily Kelp () Intake on Body Composition, Serum Lipid Levels, and Thyroid Hormone Levels in Healthy Japanese Adults: A Randomized, Double-Blind Study. Mar Drugs. 2021; 19(7). PMC: 8307228. DOI: 10.3390/md19070352. View

Askin L, Duman H, Ozyildiz A, Tanriverdi O, Turkmen S . Association between Omentin-1 and Coronary Artery Disease: Pathogenesis and Clinical Research. Curr Cardiol Rev. 2020; 16(3):198-201. PMC: 7536812. DOI: 10.2174/1573403X16666200511085304. View

Butnariu L, Gorduza E, Tarca E, Panzaru M, Popa S, Stoleriu S . Current Data and New Insights into the Genetic Factors of Atherogenic Dyslipidemia Associated with Metabolic Syndrome. Diagnostics (Basel). 2023; 13(14). PMC: 10378477. DOI: 10.3390/diagnostics13142348. View

Deiuliis J . MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics. Int J Obes (Lond). 2015; 40(1):88-101. PMC: 4722234. DOI: 10.1038/ijo.2015.170. View

Gabbia D, De Martin S . Brown Seaweeds for the Management of Metabolic Syndrome and Associated Diseases. Molecules. 2020; 25(18). PMC: 7570850. DOI: 10.3390/molecules25184182. View

10.

Levine J, Oleaga C, Eren M, Amaral A, Shang M, Lux E . Role of PAI-1 in hepatic steatosis and dyslipidemia. Sci Rep. 2021; 11(1):430. PMC: 7801442. DOI: 10.1038/s41598-020-79948-x. View

11.

Rus M, Crisan S, Andronie-Cioara F, Indries M, Marian P, Pobirci O . Prevalence and Risk Factors of Metabolic Syndrome: A Prospective Study on Cardiovascular Health. Medicina (Kaunas). 2023; 59(10). PMC: 10608643. DOI: 10.3390/medicina59101711. View

12.

Soppert J, Lehrke M, Marx N, Jankowski J, Noels H . Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting. Adv Drug Deliv Rev. 2020; 159:4-33. DOI: 10.1016/j.addr.2020.07.019. View

13.

Gunathilaka T, Samarakoon K, Ranasinghe P, Peiris L . Antidiabetic Potential of Marine Brown Algae-a Mini Review. J Diabetes Res. 2020; 2020:1230218. PMC: 7197011. DOI: 10.1155/2020/1230218. View

14.

Rafaqat S, Sharif S, Majeed M, Naz S, Manzoor F, Rafaqat S . Biomarkers of Metabolic Syndrome: Role in Pathogenesis and Pathophysiology Of Atrial Fibrillation. J Atr Fibrillation. 2021; 14(2):20200495. PMC: 8691267. DOI: 10.4022/jafib.20200495. View

15.

Zhang B, Xing L, Wang B . Dysregulation of Circulating miR-24-3p in Children with Obesity and Its Predictive Value for Metabolic Syndrome. Obes Facts. 2021; 14(5):456-462. PMC: 8546450. DOI: 10.1159/000515720. View

16.

Fahed G, Aoun L, Zerdan M, Allam S, Zerdan M, Bouferraa Y . Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int J Mol Sci. 2022; 23(2). PMC: 8775991. DOI: 10.3390/ijms23020786. View

17.

Shannon E, Conlon M, Hayes M . Seaweed Components as Potential Modulators of the Gut Microbiota. Mar Drugs. 2021; 19(7). PMC: 8303941. DOI: 10.3390/md19070358. View

18.

Zhou Z, Sun M, Jin H, Chen H, Ju H . Fetuin-a to adiponectin ratio is a sensitive indicator for evaluating metabolic syndrome in the elderly. Lipids Health Dis. 2020; 19(1):61. PMC: 7137520. DOI: 10.1186/s12944-020-01251-5. View

19.

du Preez R, Magnusson M, Majzoub M, Thomas T, Praeger C, Glasson C . Brown Seaweed as an Intervention for Diet-Induced Obesity in Male Wistar Rats. Nutrients. 2021; 13(6). PMC: 8224310. DOI: 10.3390/nu13061754. View

20.

Makiel K, Suder A, Targosz A, Maciejczyk M, Koziol-Kozakowska A, Haim A . Impact of Two Types of Exercise Interventions on Leptin and Omentin Concentrations and Indicators of Lipid and Carbohydrate Metabolism in Males with Metabolic Syndrome. J Clin Med. 2023; 12(8). PMC: 10144374. DOI: 10.3390/jcm12082822. View